Navigation Links
XTL in Medical News

Notification of Annual General Meeting and Extraordinary General Meeting

...ty's site: http://www.magna.isa.gov.il . ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...he treatment of diabetic neuropathic pain and HCV. xtl is developing Bicifadine, a serotonin and norepine...

XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007

...ital well into the first quarter of 2009." ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...he treatment of diabetic neuropathic pain and HCV. xtl is developing Bicifadine, a serotonin and norepine...

XTL Announces Delisting From the Official List of the United Kingdom Listing Authority

...SDAQ, or trade their ordinary shares on the TASE. xtl Biopharmaceuticals Ltd. has further announced that...1-212-815-3004, jpaltrowitz@bankofny.com About xtl Biopharmaceuticals Ltd. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...
XTL in Medical Technology

XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma

...EHOVOT, Israel, March 18 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XT...ent for a severe and incurable blood cancer. We at xtl are thrilled at this opportunity and expect to emb...ce with the terms of the asset purchase agreement, xtl will issue Bio-GAL Ltd. ordinary shares representi...

XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain

...rly await the outcome of this study in Q4 2008." xtl in-licensed the world-wide rights to Bicifadine fr..., Inc. (NASDAQ OTC: DOVP) in January 2007. ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...

XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis

...gnificant side affects associated with it. ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...ics for the treatment of neuropathic pain and HCV. xtl is developing Bicifadine, a serotonin and norepine...

XTL Provides Update on Phase I Clinical Trial of XTL-2125

... New York, June 06, 2007 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. announced today that it ha...rved in the placebo group. Based on these results, xtl has decided to suspend further development of XTL-...f this Phase I trial concludes our research on the xtl legacy compounds that we inherited. Through an agg...
XTL in Biological Technology

Extraordinary General Meetings Statement -- XTL Also Announces Board and Management Changes

REHOVOT, Israel, March 18 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announces the results of its Extraordinary General Meetings ("EGMs") held earlier today. All of the resolutions at the EGMs were passed. The current board of directors consists of Mark...

Corrected: XTL Biopharmaceuticals to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter

VALLEY COTTAGE, N.Y., Feb. 5 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB , TASE: XTL) today provided notification that on February 3, 2009 the Company received a letter from a shareholder who owns more than 5% of the Company's outstanding ordinary shares requesting th...

Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)

VALLEY COTTAGE, N.Y., Oct. 10 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announces the results of its Extraordinary General Meetings ("EGMs") held earlier today. The outcome of the EGMs was as follows: all of the resolutions passed and Jennifer L. Good ...

XTL to Appeal NASDAQ Staff Determination; XTL May Transfer its ADR Listing to the NASDAQ Capital Market

VALLEY COTTAGE, New York, September 26 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL) today announced that on September 24, 2007, the Company received a NASDAQ Staff Determination indicating that the Company fails to comply with the minimum $10 mill...

Reminder: XTL to Hold a Conference Call Today at 8:30 am EDT to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain

VALLEY COTTAGE, New York, September 11 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL) will hold a conference call today, September 11, 2007, at 8:30 a.m. EDT to discuss the Phase IIb clinical trial of Bicifadine for the treatment of diabetic neuropa...

XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market

NEW YORK, August 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL), a biopharmaceutical company engaged in the acquisition, development and commercialization of therapeutics for the treatment of unmet medical needs, particularly neuropathic pain and...

Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer

...f all of our stakeholders." Ron Bentsur has more than a decade of experience in the biotech industry. Most recently, Mr. Bentsur served as CEO of xtl Biopharmaceuticals, a position he held from January 2006 until April 2009. Prior to his tenure at XTL, Mr. Bentsur was with the Company from 2000-200...

XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel

...EHOVOT, Israel, April 16 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. (Nasdaq: XTLB , TASE: XT... proceed with the delisting process. ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...

XTL Biopharmaceuticals Ltd. Extraordinary General Meetings Postponed Until March 18, 2009

... VALLEY COTTAGE, N.Y., March 11 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announced today that its Extraordinary General Meetings ("EGMs") were postponed for one week in a...

XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors

...Mr. Shweiger received an LL.B, magna cum laude, from the College of Management and an MBA in finance and auditing from Tel - Aviv University . xtl also announced that its appeal hearing date for its Nasdaq listing has been changed to March 19, 2009 from March 12, 2009. Cautionary Statemen...
Other Tags
(Date:9/17/2014)... 17, 2014 In its latest blog post, ... believes that having family close by during a stay in ... the process is successful, is highlighting a member of the ... the lives of addicts across the country and around the ... can reduce the blood pressure, heart rate, and stress levels ...
(Date:9/17/2014)... sound like the ideas of a science fiction ... an exciting new approach to imaging local and ... prostate cancer, scientists at Virginia Commonwealth University Massey ... Johns Hopkins Medical Institutions have provided proof-of-principle of ... doctors, ability to see tumors that have metastasized ...
(Date:9/17/2014)... NY (PRWEB) September 17, 2014 In ... acknowledges that “bi-weekly telephonic discovery conferences would be beneficial ... such conferences through mid-December. “At the end of December,” ... assess the need for additional conferences. , “The ... recognizes that there is still much to be discussed ...
(Date:9/17/2014)... Dennis Thompson HealthDay Reporter ... in the womb to household chemicals known as phthalates ... Columbia University researchers reported in a new study. ... developing asthma between age 5 and 11 if their ... two phthalates (pronounced thal-ates), the researchers found. The two ...
(Date:9/17/2014)... The Scripps Research Institute (TSRI) have devised a ... effective against vancomycin-resistant strains of MRSA and other ... to have not one but two distinct mechanisms ... evolve resistance quickly. , "This is the prototype ... in clinical use a generation or maybe even ...
Breaking Medicine News(10 mins):Health News:Latest Best Drug Rehabilitation Blog Post Highlights How Dogs are Helping Addicts Recover 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 3Health News:Transvaginal Mesh Lawsuit News: New Order in C.R. Bard MDL Sets Schedule of Conferences for September to December, the Rottenstein Law Group LLP Reports 2Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 2Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 3Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 4Health News:Scripps Research Institute chemists modify antibiotic to vanquish resistant bacteria 2Health News:Scripps Research Institute chemists modify antibiotic to vanquish resistant bacteria 3
(Date:9/17/2014)... Arts and Humanities has received a $260,000 grant from ... "The Boundaries of the Human in the Age of ... wide-ranging series of events aimed at exploring two compelling ... and researchers who are exploring the boundaries of our ... and the other involves the increasingly influential hypothesis that ...
(Date:9/17/2014)... "Nature has developed, very cleverly, some lessons on how ... design," said Joseph Shaw, director of the Optical Technology ... and structures at the nanoscale, we,ll discover them." , ... in August during a conference called "The Nature of ... Liang of the University of Arizona College of Optical ...
(Date:9/17/2014)... researchers have obtained the first partial genome sequence of ... found at the site of the Montsoriu Castle in ... is closely related to today,s Iberian pig. Researchers also ... modern Iberian pigs. , The study, published in ... pig species, and particularly on that of the Iberian ...
Breaking Biology News(10 mins):Mellon Foundation awards grant for major project in the humanities and sciences 2Nature's designs inspire research into new light-based technologies 2Nature's designs inspire research into new light-based technologies 3Iberian pig genome remains unchanged after 5 centuries 2
Other Contents